Apoptosis and bcl-2 oncogene expression in Wilms' tumor

Pediatric Surgery International

Volumn 15, Issue 3-4, 1999, Pages 243-247

  Tanaka, K ^a   Granata, C ^a   Wang, Y ^a   O'Briain, D S ^a   Puri, P ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Apoptosis; Bcl 2; Wilms' tumo

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEPHROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTO ONCOGENE; SCHOOL CHILD; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENES, BCL-2; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; WILMS TUMOR;

EID: 0033061710     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003830050567     Document Type: Article

References (22)

1. Beckwith JB (1986) The John Lattimer lecture. Wilms' tumor and other renal tumors of childhood: an update. J Urol 136: 320
2. Wyllie AH (1992) Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 11: 95-103
3. Cotter TG, Lennon SV, Glynn JG. et al (1990) Cell death via apoptosis and its relationship to growth, development and differentiation of both tumor and normal cells. Anticancer Res 10: 1153-1160
4. Raff MC (1992) Social controls on cell survival and cell death. Nature 356: 397-400
5. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basis biological phenomenon with wideranging implications in tissue kinetics. Br J Cancer 26: 239-257
6. Korsmeyer SJ (1992) Bcl-2: an antidote to programmed cell death. Cancer Surv 15: 105-118
7. McDonnell TJ, Troncoso P, Brisbay SM (1992) Expression of the protooncogene bcl-2 in the prostate and its association in the emergence of androgen-independent prostate cancer. Cancer Res 52: 6940-6944
8. Bronner MP, Culin C, Reed JC, et al (1995) the bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146: 20-26
9. Chandler D, El-Naggar AK, Brisbay S, et al (1994) Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis. Hum Pathol 25: 789-796
10. Ikeda H, Hirato J, Akami M, et al (1995) Bcl-2 oncoprotein expression and apoptosis in neuroblastoma. J Pediatr Surg 30 (6): 805-888
11. Green DM, D'Angio GJ, Beckwith JB, et al (1997) Wilms' tumor (nephroblastoma, renal embryoma). In: Pizzo PA, Poplack DG (eds) Principles and practice of paediatric oncology. Lippincot-Raven, Philadelphia, pp 733-759
12. Zuppan CW, Beckwith JB, Luckey DW (1988) Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study pathology centre. Hum Pathol 19: 1199-1209
13. Wyllie AH (1985) The biology of cell death in tumors. Anti-cancer Res 5: 131-136
14. Staunton MJ, Gaffney EF (1995) Tumor type is determinant of susceptibility to apoptosis. Am J Clin Pathol 103: 300-307
15. Akagi Y, Ito K, Sawada S (1993) Radiation-induced apoptosis and necrosis in Molt-4 cells: a study of dose-effect relationships and their modification. Int J Radiat Biol 1: 47-56
16. Pileri S, Poggi S, Sabattini E (1994) Apoptosis as programmed cell death (PCD): cupio dissolvi in cell life. Curr Diagn Pathol 1: 48-55
17. Gaffney EF, O'Neill A, Staunton MJ (1994) Bcl-2 and prognosis is non-small-cell lung carcinoma. N Enel J Med 330: 1757-1758
18. One T, Fukuzawa M, Kusafuka T. et al (1996) In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: relation to apoptosis and spontaneous regression. J Pediatr Surg 31: 251-257
19. Tomita Y, Bilim V, Kawasaki T. et al (1996) Frequent expression of bcl-2 in renal-cell carcinomas carrying wild type p53. Int J Cancer 66: 322-325
20. Bardeesy N, Beckwith JB, Pelletier J (1995) Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res 55: 215-219
21. Lowe SW, Rulcy HE, Jacks T, et al (1993) p-53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967
22. Sysmonds H, Krall L, Remington L, et al (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78: 703-711